CivicBeaconCivicBeacon
Health
HR7693
Senate
119th Congress

To mitigate the effects of the COVID-19 pandemic on incentives under the Federal Food, Drug, and Cosmetic Act for the development of orphan drugs, and for other purposes.

Referred to the House Committee on Energy and Commerce.

Recent Activity

Referred to the House Committee on Energy and Commerce.

2/25/2026IntroReferral

Introduced in House

2/25/2026IntroReferral

Introduced in House

2/25/2026IntroReferral

Viewing 3 of 3 actions

Get the full experience in the app

View more details and get real-time updates in the CivicBeacon app.

  • ✓Complete voting history
  • ✓Push notifications
  • ✓Save representatives
  • ✓Personal analytics (Premium)
Get the App

Sponsors

Rep. Gottheimer, Josh [D-NJ-5]

Rep. Gottheimer, Josh [D-NJ-5]

D - NJ

Details

Introduced
2/25/2026